大幸薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/01/25 | 2,543 | 2,543 | 2,481 | 2,485 | -48 | -1.9% | 34,800 |
2018/01/24 | 2,501 | 2,541 | 2,488 | 2,533 | +35 | +1.4% | 62,300 |
2018/01/23 | 2,520 | 2,562 | 2,484 | 2,498 | +2 | +0.1% | 109,200 |
2018/01/22 | 2,400 | 2,508 | 2,400 | 2,496 | +103 | +4.3% | 154,700 |
2018/01/19 | 2,377 | 2,405 | 2,363 | 2,393 | +16 | +0.7% | 61,900 |
2018/01/18 | 2,455 | 2,456 | 2,359 | 2,377 | -28 | -1.2% | 116,100 |
2018/01/17 | 2,408 | 2,422 | 2,376 | 2,405 | -3 | -0.1% | 34,900 |
2018/01/16 | 2,437 | 2,437 | 2,397 | 2,408 | -30 | -1.2% | 22,300 |
2018/01/15 | 2,461 | 2,466 | 2,411 | 2,438 | ±0 | ±0% | 32,300 |
2018/01/12 | 2,376 | 2,467 | 2,376 | 2,438 | +62 | +2.6% | 79,900 |
2018/01/11 | 2,382 | 2,385 | 2,352 | 2,376 | +4 | +0.2% | 30,300 |
2018/01/10 | 2,355 | 2,379 | 2,340 | 2,372 | +25 | +1.1% | 34,700 |
2018/01/09 | 2,357 | 2,365 | 2,341 | 2,347 | -6 | -0.3% | 27,600 |
2018/01/05 | 2,366 | 2,366 | 2,350 | 2,353 | -1 | ±0% | 31,700 |
2018/01/04 | 2,335 | 2,363 | 2,333 | 2,354 | -30 | -1.3% | 48,600 |
2017/12/29 | 2,379 | 2,413 | 2,365 | 2,384 | +23 | +1% | 68,600 |
2017/12/28 | 2,322 | 2,370 | 2,322 | 2,361 | +39 | +1.7% | 37,000 |
2017/12/27 | 2,290 | 2,329 | 2,290 | 2,322 | +28 | +1.2% | 18,700 |
2017/12/26 | 2,306 | 2,325 | 2,291 | 2,294 | -16 | -0.7% | 47,700 |
2017/12/25 | 2,314 | 2,326 | 2,303 | 2,310 | -16 | -0.7% | 39,100 |
2017/12/22 | 2,335 | 2,361 | 2,320 | 2,326 | -3 | -0.1% | 54,500 |
2017/12/21 | 2,327 | 2,333 | 2,317 | 2,329 | +5 | +0.2% | 35,400 |
2017/12/20 | 2,331 | 2,339 | 2,317 | 2,324 | -8 | -0.3% | 37,900 |
2017/12/19 | 2,332 | 2,343 | 2,328 | 2,332 | -6 | -0.3% | 51,900 |
2017/12/18 | 2,358 | 2,358 | 2,327 | 2,338 | -17 | -0.7% | 49,300 |
2017/12/15 | 2,387 | 2,387 | 2,346 | 2,355 | -16 | -0.7% | 44,500 |
2017/12/14 | 2,373 | 2,393 | 2,356 | 2,371 | +2 | +0.1% | 53,200 |
2017/12/13 | 2,377 | 2,389 | 2,363 | 2,369 | -8 | -0.3% | 49,900 |
2017/12/12 | 2,376 | 2,394 | 2,373 | 2,377 | -7 | -0.3% | 31,300 |
2017/12/11 | 2,375 | 2,394 | 2,375 | 2,384 | -5 | -0.2% | 32,200 |
2017/12/08 | 2,371 | 2,412 | 2,371 | 2,389 | -11 | -0.5% | 50,400 |
2017/12/07 | 2,428 | 2,446 | 2,400 | 2,400 | -11 | -0.5% | 42,600 |
2017/12/06 | 2,416 | 2,437 | 2,411 | 2,411 | -19 | -0.8% | 59,700 |
2017/12/05 | 2,451 | 2,453 | 2,425 | 2,430 | -52 | -2.1% | 53,000 |
2017/12/04 | 2,524 | 2,532 | 2,481 | 2,482 | -43 | -1.7% | 75,400 |
2017/12/01 | 2,518 | 2,565 | 2,518 | 2,525 | +12 | +0.5% | 59,900 |
2017/11/30 | 2,496 | 2,523 | 2,495 | 2,513 | +16 | +0.6% | 33,800 |
2017/11/29 | 2,509 | 2,519 | 2,492 | 2,497 | -11 | -0.4% | 23,900 |
2017/11/28 | 2,555 | 2,558 | 2,507 | 2,508 | -30 | -1.2% | 36,300 |
2017/11/27 | 2,558 | 2,558 | 2,535 | 2,538 | -21 | -0.8% | 29,500 |
2017/11/24 | 2,588 | 2,597 | 2,556 | 2,559 | -30 | -1.2% | 31,200 |
2017/11/22 | 2,601 | 2,607 | 2,585 | 2,589 | -21 | -0.8% | 45,600 |
2017/11/21 | 2,631 | 2,658 | 2,609 | 2,610 | -44 | -1.7% | 48,900 |
2017/11/20 | 2,611 | 2,664 | 2,582 | 2,654 | +54 | +2.1% | 102,100 |
2017/11/17 | 2,482 | 2,624 | 2,482 | 2,600 | +128 | +5.2% | 165,800 |
2017/11/16 | 2,421 | 2,485 | 2,421 | 2,472 | +43 | +1.8% | 40,000 |
2017/11/15 | 2,412 | 2,474 | 2,412 | 2,429 | -19 | -0.8% | 57,500 |
2017/11/14 | 2,413 | 2,473 | 2,412 | 2,448 | -3 | -0.1% | 64,000 |
2017/11/13 | 2,474 | 2,509 | 2,429 | 2,451 | -119 | -4.6% | 103,100 |
2017/11/10 | 2,527 | 2,589 | 2,491 | 2,570 | +4 | +0.2% | 91,800 |
1851~
1900
件表示中 / 4021件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステムリム | 31,500円 | - | - | 0.00% | - | 2.90倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
オンコリス | 71,200円 | +3771.0% | - | 0.00% | - | 12.41倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
市場注目の銘柄
チャート関連のコラム